Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-23

Clinical Trial Update: A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing two different dosages of isoniazid tablet formulations in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED